Background: Early stages of Alzheimer's disease (AD) are characterized by high phosphorylation of microtubule-associated protein tau, which may result from the downregulation of protein phosphatases.
New method: In order to model phosphatase downregulation and analyze its effect on tau aggregation in vitro, we treated neuroblastoma SH-SY5Y cells with okadaic acid (OA), a protein phosphatase inhibitor, and examined high molecular weight phospho-tau species.
Results and comparison with existing methods: OA treatment led to the appearance of heat-stable protein species with apparent molecular weight around 100 kDa, which were immunoreactive to anti-tau antibodies against phosphorylated Ser202 and Ser396. As these high molecular weight tau-immunoreactive proteins (HMW-TIPs) corresponded to the predicted size of two tau monomers, we considered the possibility that they represent phosphorylation-induced tau oligomers. We attempted to dissociate HMW-TIPs by urea and guanidine, as well as by alkaline phosphatase treatment, but HMW-TIPs were stable under all conditions tested. These characteristics resemble properties of certain sodium dodecyl sulfate (SDS)-resistant tau oligomers from AD brains. The absence of HMW-TIPs detection by anti-total tau antibodies Tau46, CP27 and Tau13 may be a consequence of epitope masking and protein truncation. Alternatively, HMW-TIPs may represent previously unreported phosphoproteins cross-reacting with tau.
Conclusions: Taken together, our data provide a novel characterization of an OA-based cell culture model in which OA induces the appearance of HMW-TIPs. These findings have implications for further studies of tau under the conditions of protein phosphatase downregulation, aiming to explain mechanisms involved in early events leading to AD.
Keywords: Alzheimer’s disease; Cell culture; Immunoblot; Neurodegeneration; Okadaic acid; Oligomerization; Phosphorylation; Protein phosphatase; SH-SY5Y; Tau protein.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease.Front Aging Neurosci. 2018 Feb 6;10:27. doi: 10.3389/fnagi.2018.00027. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29472853 Free PMC article.
Reversible heat stress-related loss of phosphorylated Alzheimer-type epitopes in Tau proteins of human neuroblastoma cells.J Neurosci. 1993 Nov;13(11):4854-60. doi: 10.1523/JNEUROSCI.13-11-04854.1993. J Neurosci. 1993. PMID: 7693894 Free PMC article.
Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.Exp Neurol. 1994 Apr;126(2):185-94. doi: 10.1006/exnr.1994.1057. Exp Neurol. 1994. PMID: 7925819
SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.Eur J Pharm Sci. 2017 Dec 15;110:101-108. doi: 10.1016/j.ejps.2017.03.037. Epub 2017 Mar 27. Eur J Pharm Sci. 2017. PMID: 28359686
Anesthesia and tau pathology.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:147-55. doi: 10.1016/j.pnpbp.2013.03.004. Epub 2013 Mar 25. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23535147 Free PMC article. Review.
Cited by 3 articles
Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases.J Ophthalmic Vis Res. 2019 Oct 24;14(4):491-505. doi: 10.18502/jovr.v14i4.5459. eCollection 2019 Oct-Dec. J Ophthalmic Vis Res. 2019. PMID: 31875105 Free PMC article. Review.
Novel Peptidomic Approach for Identification of Low and High Molecular Weight Tauopathy Peptides Following Calpain Digestion, and Primary Culture Neurotoxic Challenges.Int J Mol Sci. 2019 Oct 21;20(20):5213. doi: 10.3390/ijms20205213. Int J Mol Sci. 2019. PMID: 31640160 Free PMC article.
Role of Microglial Cells in Alzheimer's Disease Tau Propagation.Front Aging Neurosci. 2019 Oct 4;11:271. doi: 10.3389/fnagi.2019.00271. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31636558 Free PMC article.